Nucleic Acids Research Advance Access originally published online on March 1, 2007
Nucleic Acids Research 2007 35(6):1919-1932; doi:10.1093/nar/gkl1092
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2007, Vol. 35, No. 6 1919-1932
© 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Molecular Biology |
Switched alternative splicing of oncogene CoAA during embryonal carcinoma stem cell differentiation
1Institute of Molecular Medicine and Genetics and 2Department of Pathology, Medical College of Georgia, Augusta, GA 30912, USA
*To whom correspondence should be addressed. +1 706 721 8758 +1 706 721 8752 lko{at}mcg.edu
Received July 24, 2006. Revised November 20, 2006. Accepted November 29, 2006.
Alternative splicing produces functionally distinct proteins participating in cellular processes including differentiation and development. CoAA is a coactivator that regulates transcription-coupled splicing and its own pre-mRNA transcript is alternatively spliced. We show here that the CoAA gene is embryonically expressed and alternatively spliced in multiple tissues to three splice variants, CoAA, CoAM and CoAR. During retinoic-acid-induced P19 stem cell differentiation, the expression of CoAA undergoes a rapid switch to its dominant negative splice variant CoAM in the cavity of the embryoid body. CoAM functionally inhibits CoAA, and their switched expression up-regulates differentiation marker Sox6. Using a CoAA minigene cassette, we find that the switched alternative splicing of CoAA and CoAM is regulated by the cis-regulating sequence upstream of the CoAA basal promoter. Consistent to this, we show that p54nrb and PSF induce CoAM splice variant through the cis-regulating sequence. We have previously shown that the CoAA gene is amplified in human cancers with a recurrent loss of this cis-regulating sequence. These results together suggest that the upstream regulatory sequence contributes to alternative splicing of the CoAA gene during stem cell differentiation, and its selective loss in human cancers potentially deregulates CoAA alternative splicing and alters stem cell differentiation.
Zheqiong Yang is in the International Graduate Exchange Trainee Program between Medical College of Georgia and Wuhan University, China.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. S. Brooks, G. Wang, Z. Yang, K. K. Smith, E. Bieberich, and L. Ko Functional Pre- mRNA trans-Splicing of Coactivator CoAA and Corepressor RBM4 during Stem/Progenitor Cell Differentiation J. Biol. Chem., July 3, 2009; 284(27): 18033 - 18046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Conway-Campbell, A. J. Brooks, P. J. Robinson, M. Perani, and M. J. Waters The Extracellular Domain of the Growth Hormone Receptor Interacts with Coactivator Activator to Promote Cell Proliferation Mol. Endocrinol., September 1, 2008; 22(9): 2190 - 2202. [Abstract] [Full Text] [PDF]
|
|